journal article·2024-11Open access

3D‐Printed Latticed Microneedle Array Patches for Tunable and Versatile Intradermal Delivery

Netra U. Rajesh, Jihyun (Luna) Hwang, Yue Xu, Max A. Saccone, Andy H. Hung, Rosa A.S. Hernandez, Ian A. Coates, Madison M. Driskill, Maria T. Dulay, Gunilla B. Jacobson, Shaomin Tian, Jillian L. Perry, Joseph M. DeSimone

Advanced Materials· Volume 36· Issue 44

Abstract

Abstract Using high‐resolution 3D printing, a novel class of microneedle array patches (MAPs) is introduced, called latticed MAPs (L‐MAPs). Unlike most MAPs which are composed of either solid structures or hollow needles, L‐MAPs incorporate tapered struts that form hollow cells capable of trapping liquid droplets. The lattice structures can also be coated with traditional viscous coating formulations, enabling both liquid‐ and solid‐state cargo delivery, on a single patch. Here, a library of 43 L‐MAP designs is generated and in‐silico modeling is used to down‐select optimal geometries for further characterization. Compared to traditionally molded and solid‐coated MAPs, L‐MAPs can load more cargo with fewer needles per patch, enhancing cargo loading and drug delivery capabilities. Further, L‐MAP cargo release kinetics into the skin can be tuned based on formulation and needle geometry. In this work, the utility of L‐MAPs as a platform is demonstrated for the delivery of small molecules, mRNA lipid nanoparticles, and solid‐state ovalbumin protein. In addition, the production of programmable L‐MAPs is demonstrated with tunable cargo release profiles, enabled by combining needle geometries on a single patch.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Ocular Surface and Contact Lens · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiology Stanford University Stanford CA 94305 USA

Department of Bioengineering Stanford University Stanford CA 94305 USA

Department of Chemical Engineering Stanford University Stanford CA 94305 USA

Department of Microbiology and Immunology University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA

Center for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA

Funding

Bill and Melinda Gates Foundation · Wellcome Leap

References (50)

Show source-provided references
1. Gerstel M. S. · Drug Delivery Device · 1976
2. 10.1021/jacsau.2c0043210.1021/jacsau.2c00432 ↗
3. 10.3389/fimmu.2022.96304910.3389/fimmu.2022.963049 ↗
4. 10.1016/B978-0-323-55435-0.00009-410.1016/B978-0-323-55435-0.00009-4 ↗
5. 10.1021/js98004210.1021/js980042 ↗
6. “Polymers | Free Full‐Text | A Comprehensive Review of Microneedles: Types Materials Processes Characterizations and Applications ” can be found underhttps://www.mdpi.com/2073‐4360/13/16/2815. (accessed: February 2024).10.3390/polym13162815 ↗
7. 10.1007/s10544-014-9836-610.1007/s10544-014-9836-6 ↗
8. 10.1088/0960-1317/16/3/00110.1088/0960-1317/16/3/001 ↗
9. 10.1007/s10544-024-00694-210.1007/s10544-024-00694-2 ↗
10. 10.1016/j.addr.2012.04.00510.1016/j.addr.2012.04.005 ↗
11. 10.1126/science.aaa239710.1126/science.aaa2397 ↗
12. 10.1073/pnas.210259511810.1073/pnas.2102595118 ↗
13. 10.1126/sciadv.abq284610.1126/sciadv.abq2846 ↗
14. 10.1002/jps.2343910.1002/jps.23439 ↗
15. 10.2174/187421060090301020210.2174/1874210600903010202 ↗
16. 10.1016/j.biomaterials.2003.09.02910.1016/j.biomaterials.2003.09.029 ↗
17. “KeyPrint KEYSPLINT HARD technical data sheet ” can be found underhttps://keyprint.keystoneindustries.com/wp‐content/uploads/2021/07/KeySplinthard_TDS_R5.pdf(accessed: February 2024).
18. 10.1115/1.315365810.1115/1.3153658 ↗
19. 10.3390/pharmaceutics1404076610.3390/pharmaceutics14040766 ↗
20. 10.1007/s40820-021-00611-910.1007/s40820-021-00611-9 ↗
21. 10.1016/j.bioactmat.2023.09.02210.1016/j.bioactmat.2023.09.022 ↗
22. 10.1080/01694243.2012.70510110.1080/01694243.2012.705101 ↗
23. 10.1016/j.ejpb.2016.06.02310.1016/j.ejpb.2016.06.023 ↗
24. 10.1038/s41587-023-01774-z10.1038/s41587-023-01774-z ↗
25. 10.1007/s11095-011-0524-410.1007/s11095-011-0524-4 ↗
26. 10.1016/j.ijpharm.2021.12129510.1016/j.ijpharm.2021.121295 ↗
27. 10.1016/j.jconrel.2024.01.01010.1016/j.jconrel.2024.01.010 ↗
28. 10.1016/j.ejpb.2014.05.00310.1016/j.ejpb.2014.05.003 ↗
29. 10.1371/journal.pone.022038210.1371/journal.pone.0220382 ↗
30. 10.1371/journal.pmed.100302410.1371/journal.pmed.1003024 ↗
31. 10.1080/21645515.2022.205012310.1080/21645515.2022.2050123 ↗
32. 10.1021/acsomega.7b0034310.1021/acsomega.7b00343 ↗
33. 10.1016/j.jvacx.2023.10039810.1016/j.jvacx.2023.100398 ↗
34. 10.1023/A:101360740004010.1023/A:1013607400040 ↗
35. 10.1021/nn304235j10.1021/nn304235j ↗
36. 10.1016/j.jconrel.2009.06.02910.1016/j.jconrel.2009.06.029 ↗
37. 10.1007/s11095-013-1137-x10.1007/s11095-013-1137-x ↗
38. 10.1002/adfm.20210335910.1002/adfm.202103359 ↗
39. 10.1038/s41573-021-00283-510.1038/s41573-021-00283-5 ↗
40. 10.1002/adhm.20190063510.1002/adhm.201900635 ↗
41. 10.1039/C9MH01838G10.1039/C9MH01838G ↗
42. 10.1016/j.jconrel.2014.08.02110.1016/j.jconrel.2014.08.021 ↗
43. 10.1016/j.omtn.2018.03.00510.1016/j.omtn.2018.03.005 ↗
44. 10.3390/mi1211132110.3390/mi12111321 ↗
45. 10.3390/polym1408160810.3390/polym14081608 ↗
46. 10.1007/s11095-020-02844-610.1007/s11095-020-02844-6 ↗
47. 10.1089/15383440232088259310.1089/153834402320882593 ↗
48. 10.1128/AEM.00778-1310.1128/AEM.00778-13 ↗
49. 10.3390/jcm911353810.3390/jcm9113538 ↗
50. 10.1038/s41551-020-00650-410.1038/s41551-020-00650-4 ↗